EUVIMEDEUVIMED entdecken
Crossref

Positive Allosteric Modulation of Antithrombin's Inhibitory Activity by RNA Aptamers

Khalequz Zaman, Adi Breitman, Isa Malik, Yolanda M Fortenberry iD

Nucleic Acid Therapeutics · 2023

DOI: 10.1089/nat.2022.0047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acid Therapeutics, 2023. Verfasst von Khalequz Zaman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biology Department, Case Western Reserve University, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Aptamers, Nucleotide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aptamers, NucleotideFactor XaThrombinAnticoagulantsHeparinAntithrombins

Stichwörter der Autor:innen

RNAanticoagulantsantithrombinaptamerheparin

Substanzen

Aptamers, NucleotideFactor XaThrombinAnticoagulantsHeparinAntithrombins

Autor:innen und Institutionen

  • Biology Department, Case Western Reserve University, Cleveland, Ohio, USA.

ORCID-Profile: Yolanda M Fortenberry

Zitieren

APA

Zaman, K., Breitman, A., Malik, I., & Fortenberry, Y. M. (2023). Positive Allosteric Modulation of Antithrombin's Inhibitory Activity by RNA Aptamers. Nucleic Acid Therapeutics. https://doi.org/10.1089/nat.2022.0047

Vancouver

Zaman K, Breitman A, Malik I, Fortenberry YM. Positive Allosteric Modulation of Antithrombin's Inhibitory Activity by RNA Aptamers. Nucleic Acid Therapeutics. 2023. doi:10.1089/nat.2022.0047

BibTeX
@article{Zaman2023,
  author = {Zaman, Khalequz and Breitman, Adi and Malik, Isa and Fortenberry, Yolanda M},
  title = {Positive Allosteric Modulation of Antithrombin's Inhibitory Activity by RNA Aptamers},
  journal = {Nucleic Acid Therapeutics},
  year = {2023},
  doi = {10.1089/nat.2022.0047}
}
Kostenlos starten →